# Antigenics

Antigenics is an Asset Manager based in Lexington, United States.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Lexington, United States
- **Region:** North America
- **Address:** Lexington, United States
- **Assets under management:** Undisclosed
- **Website:** https://antigenics.com

## Regulatory record

- **Reports private funds:** No

## About

Antigenics (NASDAQ: AGEN) is a biotechnology company focused on developing treatments for cancers and infectious diseases.

## Questions

### What is Antigenics' investment strategy?

The firm invests in healthcare and technology assets, including public equities and private placements. It focuses on translational medicine and orphan drug development, but also holds a diversified portfolio of marketable securities. Strategy involves direct equity stakes and partnerships with research institutions.

### What sectors does Antigenics focus on?

Sector focus is primarily healthcare, including biotechnology, orphan drugs, and medical technology. The firm has also shown interest in broader technology investments, though the exact composition of its portfolio is not publicly detailed.

### Does Antigenics have any recent investment activity?

No recent investment activity is publicly documented. The firm has limited transparency regarding its current portfolio or new deals. Prior major events include the restructuring of the company following the failure of its lead cancer vaccine candidate in 2016.

## Related profiles

- [Air Transport Services Group](https://altss.com/profile/air-transport-services-group)
- [Boom Ventures](https://altss.com/profile/boom-ventures)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/antigenics

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology